SCHEMBL16002007

SCHEMBL16002007

OCCN[C@H]1CC[C@H](O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.41
SPHK1 Q9NYA1 1/20 0.38
KDM4E B2RXH2 1/20 0.36
KDM1A O60341 2/20 0.36
LMNA P02545 1/20 0.35
GBA1 P04062 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CNR1 P21554 1/20 0.35
TBXA2R P21731 1/20 0.35
HRH2 P25021 1/20 0.35
SLC6A4 P31645 1/20 0.35
KCNH2 Q12809 1/20 0.35
HIF1A Q16665 1/20 0.35
TSHR P16473 2/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
DPP4 P27487 1/20 0.33
AXL P30530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL516047 1.00 EPHX2 (0.41) EPHX2SPHK1KDM4EKDM1ALMNA
SCHEMBL701060 0.89
SCHEMBL18045582 0.89 SPHK1 (0.42) SPHK1KDM4EKDM1ADPP4
Bromide SCHEMBL2833578 0.87
SCHEMBL1796153 0.86 KDM4E (0.40) EPHX2SPHK1KDM4ELMNAGBA1
SCHEMBL1484842 0.79
SCHEMBL3429410 0.79
SCHEMBL24429571 0.78 ALDH1A1 (0.41) SPHK1KDM4EKDM1ATSHR
SCHEMBL1795636 0.78 EPHX2 (0.39) EPHX2KDM4ELMNAGBA1CYP1A2
SCHEMBL24429564 0.78 ALDH1A1 (0.41) SPHK1KDM4EKDM1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3239154-A1 IRAK INHIBITORS AND USES THEREOF Nimbus Iris, Inc. (US) 2017-11-01 EP disclosed
EP-2663312-B1 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS INC (US) 2017-10-11 EP disclosed
WO-2013106535-A9 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS, INC. (US) 2014-09-04 WO disclosed